The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine

Psychopharmacology (Berl). 1994 May;114(4):597-600. doi: 10.1007/BF02244990.

Abstract

Modafinil is a new drug used in the treatment of narcolepsy. Its administration in mice induced a dose-dependent increase in locomotor activity. The effects of modafinil were compared with those of dexamphetamine on three tests that assessed the anxiety level (drugs were used at doses which induced a roughly similar stimulation of locomotor activity). Dexamphetamine increased the latency of exploration of a white compartment, increased thigmotaxis in an open-field and decreased the time spent in the open arms of an elevated plus-maze. None of these responses was significantly modified by modafinil. We conclude that modafinil does not share the anxiogenic effects of dexamphetamine.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anxiety / psychology*
  • Benzhydryl Compounds / pharmacology*
  • Central Nervous System Stimulants / pharmacology*
  • Dextroamphetamine / pharmacology*
  • Exploratory Behavior / drug effects
  • Male
  • Mice
  • Modafinil
  • Motor Activity / drug effects
  • Movement / drug effects
  • Wakefulness / drug effects*

Substances

  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • Modafinil
  • Dextroamphetamine